Nörosistiserkozis
Özet
Nörosistiserkozis, Taenia solium parazitinin beyinde kistler oluşturmasıyla meydana gelen ve merkezi sinir sistemini etkileyen en sık görülen paraziter enfeksiyondur. Özellikle gelişmekte olan ülkelerde epilepsinin başlıca enfeksiyöz sebebi olarak öne çıkan bu hastalık, kötü hijyen koşulları ve fekal-oral bulaşma yoluyla yayılmaktadır. Tanı, klinik şüphe, nörogörüntüleme yöntemleri ve serolojik testlerin kombinasyonuyla konulmaktadır. Tedavi süreci, parazitin evresine ve lezyonların yerleşimine göre antiepileptik ilaçlar, antiparaziter ajanlar ve kortikosteroidler kullanılarak bireyselleştirilmektedir.
Neurocysticercosis is the most common parasitic infection of the central nervous system, characterized by cysts in the brain caused by the larval form of the tapeworm Taenia solium. As the leading infectious cause of epilepsy in developing countries, it is primarily transmitted through the ingestion of contaminated food or poor hygiene practices. Diagnosis relies on a combination of clinical suspicion, neuroimaging, and serological tests. Treatment strategies are highly individualized based on the stage and location of the cysts, involving a combination of antiepileptic drugs, antiparasitic therapy, and corticosteroids.
Referanslar
American Academy of Pediatrics. Tape worm diseases. In: Kimberlin DW, Brady MT, Jackson MA, Long SS (eds). Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics, 2018: 788-791
Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 2014; 13: 1202-15
Aydın Teke T, Kaman A, Gayretli Aydın ZG, Apaydın S. Yanlışlıkla Beyin Apsesi Tanısı Alan Bir Çocuk Nörosistiserkozis Olgusu. Turkiye Parazitol Derg. 2017; 41: 223-5
Erol İ, Kaya Z, Serdaroğlu A. Nörosistiserkozis: Bir Olgu Sunumu. Turkiye Klinikleri J Pediatr. 2004;13(1):40-3
Garcia HH. Neurocysticercosis. Neurol Clin. 2018;36(4):851-864
Rizvi SA, Saleh AM, Frimpong H, Al Mohiy HM, Ahmed J, Edwards RD, Ahmed SS. Neurocysticercosis: A case report and brief review. Asian Pac J Trop Med. 2016;9(1):100-2
UpToDate. Epidemiology, transmission and prevention of cysticercosis [Online]. Available at: http://www.uptodate.com/contents/epidemiology-transmission-and-prevention-of-cysticercosis.
Gonzales I, Rivera JT, Garcia HH, et al. Cysticercosis Working Group in Peru. Pathogenesis of Taenia solium taeniasis and cysticercosis. Parasite Immunol 2016; 38: 136-46
Sharma LN, Garg RK, Verma R, Singh MK, Malhotra HS. Seizure recurrence in patients with solitary cystic granuloma or single parenchymal cerebralcalcification: a comparative evaluation. Seizure 2013; 22: 840–45.
Garg RK, Potluri N, Kar AM, Singh MK, Shukla R, Agrawal A, Verma R. Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect. 2006;53(1):65-9.
Singhi P, Saini AG. Pediatric neurocysticercosis: current challenges and future prospects. Pediatric Health Med Ther. 2016;7:5-16.
White AC Jr, Coyle CM, Rajshekhar V, Singh G, et al. Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2018;66(8):e49-e75.
Del Brutto OH, Nash TE, White AC Jr, Rajshekhar V, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci. 2017;372:202-210.
